GWS
TAK icon

Glassman Wealth Services’s Takeda Pharmaceutical TAK Stock Holding History

Glassman Wealth Services’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,740
Closed -$24.8K – 1620
2023
Q4 		$24.8K Sell
1,740
-465
-21% -$6.6K ﹤0.01% 640
2023
Q3 		$34.1K Buy
2,205
+383
+21% +$5.93K 0.01% 522
2023
Q2 		$28.6K Buy
1,822
+27
+2% +$442 ﹤0.01% 541
2023
Q1 		$29.6K Buy
1,795
+178
+11% +$2.83K 0.01% 534
2022
Q4 		$25.2K Sell
1,617
-1
-0.1% -$14 ﹤0.01% 604
2022
Q3 		$21K Sell
1,618
-89
-5% -$1.24K ﹤0.01% 606
2022
Q2 		$24K Buy
1,707
+172
+11% +$2.46K ﹤0.01% 581
2022
Q1 		$22K Buy
1,535
+325
+27% +$4.77K ﹤0.01% 623
2021
Q4 		$16K Buy
1,210
+705
+140% +$9.89K ﹤0.01% 676
2021
Q3 		$8K Buy
505
+71
+16% +$1.19K ﹤0.01% 834
2021
Q2 		$7K Buy
434
+176
+68% +$3K ﹤0.01% 846
2021
Q1 		$5K Sell
258
-139
-35% -$2.5K ﹤0.01% 879
2020
Q4 		$7K Buy
397
+221
+126% +$3.88K ﹤0.01% 812
2020
Q3 		$3K Buy
176
+116
+193% +$2.11K ﹤0.01% 928
2020
Q2 		$1K Sell
60
-15
-20% -$269 ﹤0.01% 1111
2020
Q1 		$1K Buy
75
+36
+92% +$652 ﹤0.01% 989
2019
Q4 		$1K Buy
+39
New +$746 ﹤0.01% 1039

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Glassman Wealth Services's TAK Position: Q1 2024 in Review

Glassman Wealth Services sold out of Takeda Pharmaceutical (TAK) in Q1 2024, closing a stake of 1,740 shares — an estimated $24.8K sold.

Glassman Wealth Services first reported a position in TAK in Q4 2019 and held it in 17 quarters. The position peaked at $34.1K in Q3 2023. 313 funds tracked by Wall St. Rank hold TAK as of Q1 2024.

  • Glassman Wealth Services reported no remaining Takeda Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 1,740 Takeda Pharmaceutical shares in Q1 2024, an estimated $24.8K.
  • Glassman Wealth Services first reported a position in Takeda Pharmaceutical in Q4 2019 and held it in 17 quarters.
  • Glassman Wealth Services's Takeda Pharmaceutical position peaked at $34.1K in Q3 2023.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.